Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy.
17651
Phase 1 other active
Quick answer
Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy. for Locally advanced rectal cancer is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Locally advanced rectal cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active